Static and dynamic pupillary features in graves disease without orbitopathy

被引:0
|
作者
Kuskonmaz, Serife Mehlika [1 ]
Kocer, Ali Mert [2 ]
Onder, Cagatay Emir [1 ]
Sekeroglu, Mehmet Ali [3 ]
机构
[1] Ankara Numune Training & Res Hosp, Dept Endocrinol & Metab Dis, Ankara, Turkiye
[2] Ulucanlar Eye Training & Res Hosp, Dept Ophthalmol, Ankara, Turkiye
[3] Bilkent City Hosp, Dept Ophthalmol, Ankara, Turkiye
关键词
Static pupillary measurements; Dynamic pupillary measurements; Thyroid eye disease; Graves disease; Hyperthyroidism; SYMPATHETIC OVERACTIVITY; PUPILLOMETRY;
D O I
10.1007/s10792-024-03355-8
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PurposePupillary contraction and dilatation are organized by the autonomic nervous system, which can also be affected by Graves' disease (GD). In this study, it was aimed to investigate the static and dynamic pupillary responses of Graves' patients in the hyperthyroid and euthyroid periods and to compare these results with the values obtained from healthy controls. Methods48 eyes of 24 newly diagnosed Graves' patients with clinical activity score <= 2 and 46 eyes of 23 age- and sex-matched healthy controls were included in the study. Patients with GD were evaluated separately in the hyperthyroid phase and after euthyroidism was achieved. After a detailed ophthalmological examination, patients undergone automatic quantitative testing to obtain static (scotopic, mesopic, low photopic, and high photopeak pupil diameters) and dynamic (pupillary contraction amplitude, latency, velocity and duration, and pupil dilation latency, velocity and duration) pupil measurements. ResultsA statistically significant difference was found between the control [4.7 mm (3.7-6.9)] and hyperthyroid [5.1 mm (3.6-7.8)] groups for mesopic pupil diameter (p = 0.003). Dynamic pupillometry measurements showed that hyperthyroid and euthyroid groups had greater pupil dilation delay and lower pupil dilation rate compared to the control group (p < 0.05 for all). ConclusionEven in the absence of orbitopathy, patients with GD have autonomic dysregulation of pupillary functions. These changes, which prevail in the hyperthyroid phase, do not reverse when the TSH receptor antibody titer drops and the patient becomes euthyroid. Future studies are needed to elucidate the mechanism of these pupillary changes in GD.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Static and dynamic pupillary features in graves' ophthalmopathy
    Serbest Ceylanoglu, Kubra
    Sen, Emine Malkoc
    Sekeroglu, Mehmet Ali
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2023, 106 (05) : 551 - 555
  • [2] The Role of the Microbiota in Graves' Disease and Graves' Orbitopathy
    Hou, Jueyu
    Tang, Yunjing
    Chen, Yongjiang
    Chen, Danian
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [3] Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy
    Edmunds, Matthew R.
    Boelaert, Kristien
    THYROID, 2019, 29 (04) : 557 - 562
  • [4] Pupillary response changes in Graves' disease
    Bicer, Gamze Yildirim
    Onder, Cagatay Emir
    Zor, Kursad Ramazan
    CUKUROVA MEDICAL JOURNAL, 2023, 48 (02): : 361 - 368
  • [5] Retinal, choroidal and optic disc analysis in patients with Graves' disease with or without orbitopathy
    Casini, Giamberto
    Marino, Michele
    Rubino, Marisa
    Licari, Serena
    Covello, Giuseppe
    Mazzi, Barbara
    Ionni, Ilaria
    Rocchi, Roberto
    Sframeli, Angela Tindara
    Figus, Michele
    Loiudice, Pasquale
    INTERNATIONAL OPHTHALMOLOGY, 2020, 40 (09) : 2129 - 2137
  • [6] Thicknesses of the retinal layers in patients with Graves' disease with or without orbitopathy
    Ogmen, Berna Evranos
    Ugurlu, Nagihan
    Bilginer, Muhammet Cuneyt
    Polat, Sefika Burcak
    Genc, Birgul
    Ersoy, Reyhan
    Cakir, Bekir
    INTERNATIONAL OPHTHALMOLOGY, 2022, 42 (11) : 3397 - 3405
  • [7] Thicknesses of the retinal layers in patients with Graves’ disease with or without orbitopathy
    Berna Evranos Ogmen
    Nagihan Ugurlu
    Muhammet Cuneyt Bilginer
    Sefika Burcak Polat
    Birgul Genc
    Reyhan Ersoy
    Bekir Cakir
    International Ophthalmology, 2022, 42 : 3397 - 3405
  • [8] Mechanistic Pathways of Selenium in the Treatment of Graves' Disease and Graves' Orbitopathy
    Marino, Michele
    Dottore, Giovanna Rotondo
    Leo, Marenza
    Marcocci, Claudio
    HORMONE AND METABOLIC RESEARCH, 2018, 50 (12) : 887 - 893
  • [9] Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy
    G. Lanzolla
    L. Puccinelli
    M. Giudetti
    S. Comi
    F. Menconi
    M. N. Maglionico
    C. Posarelli
    M. Figus
    C. Marcocci
    M. Marinò
    Journal of Endocrinological Investigation, 2023, 46 : 337 - 344
  • [10] Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathy
    Lanzolla, G.
    Puccinelli, L.
    Giudetti, M.
    Comi, S.
    Menconi, F.
    Maglionico, M. N.
    Posarelli, C.
    Figus, M.
    Marcocci, C.
    Marino, M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2023, 46 (02) : 337 - 344